and prominent hair follicles give a peau d'orange appearance. The patches vary in size and may extend from the skin on to the dorsum of the feet. There may be increased sweating or hypertrichosis over the lesion. There are three types: (1) sharply circumscribed with nodule formation; (2) diffuse, producing solid, non-pitting oedema; (3) elephantiasis form with oedema and nodule formation.
The micropathology shows an atrophic epidermis with a flattened epidermal-dermal junction. The dermis is thickened due to an increase of mucopolysaccharide sixteen times normal, the bulk being hyaluronic acid. The latter causes the collagen to appear fragmented.
The aetiology is still unclear, but antibodies from the class of thyroid-stimulating immunoglobulins (TSI) are involved. High serum levels of TSI are found which return to normal after successful treatment. Direct stimulation of receptors on the fibroblasts is thought to cause the production of mucopolysaccharide. Serum levels of antibody equal those in the dermis, which discounts local antibody formation. Treatment involves continuous application of concentrated steroid cream under an occlusive dressing for many months. Spontaneous remission occurs in 50% but regression may be very slow.
Thyroid acropachy is a rare condition associated with pretibial myxoedema and exophthalmos. Its incidence is less than 1% and it occurs any time from weeks to over 25 years following the onset of hyperthyroidism, but more than 95% of patients develop it following treatment of thyrotoxicosis. The signs are finger and toe clubbing, and subcutaneous tissue swelling of the extremities, which are pale and firm with normal skin temperature; stiffness is the only symptom. The aetiology is thought to be similar to that in pretibial myxoedema, that is antibodies (TSI) act on the subcutaneous tissues and bones of the extremities; The -differential diagnosis is from hypertrophic pulmonary osteoarthropathy. On X-ray, spicules of new periosteal bone are seen affecting the metacarpals, classically the ulnar side of the fifth metacarpal and the radial side of the others. The proximal phalanges and the radial ends of the radius, ulna and distal phalanges may be affected. Bone scan shows areas of increased bone activity associated with radiological changes. There is no treatment available.
Thyroid-stimulating immunoglobulin (TSI) is an
IgG1. It mimics thyroid-stimulating hormone (TSH) by stimulating cyclic adenosine monophosphate production, radioactive iodine uptake and colloid droplet formation. TSI and TSH appear to compete for the same binding site on the TSH receptor. In patients with Graves' disease there are abnormalities in cell-mediated and humoral immunity. As these are controlled by T lymphocytes, it is possible that T cell control is malfunctioning. Normal control is made by suppressor T lymphocytes which suppress abnormal clones of T helper cells directed against self. In Graves' disease a randomly mutating clone of helper T cells directed against thyroid survives2, and these direct B cells to produce polyclonal thyroid autoantibodies (TSI). There is an HLA-DR3 association with Graves' diseaseand the class II major histocompatibility antigens encoded by genes in the HLA-D region are important in the presentationof antigens and regulation of immune response3. So it seems that a genetic predisposition is involved in the deficit in immune control.
Endo et al. 4 showed that TSI will bind to thyroid plus tissues outside the gland, e.g. fat cells. In this way various manifestations of an autoimmune reaction occur together, i.e. ophthalmopathy, pretibial myxoedema, thyroid acropachy. The explanation is that immune control affecting several clones of helper T-cells are made which cause antibodies (TSI) to be produced which each affect different tissues, i.e. eye, dermis, bones. Some recent work by Rennie et al.' has demonstrated in-vitro suppression of autoantibodies to thyroglobulin in Hashimoto's disease. Perhaps a similar technique could be developed to suppress the autoimmune mechanism in Graves' disease and so offer useful treatment of the signs described as an adjunct to surgery. The Royal Society of Medicine implicated as the cause of an idiosyncratic hepatitis on biochemical grounds, whereas liver biopsy showed no abnormality beyond a rather marked degree of lipofuscin deposition.
Case report A 58-year-old postal executive presented with a fouryear history of seropositive rheumatoid arthritis. He had been treated with indomethacin and phenylbutazone for two years; gold sodium thiomalate was then commenced, but had to be withdrawn at a cumulative dose of 150mg due to oral ulceration and an eczematous rash. A trial of D-penicillamine resulted in a further rash; the patient was then given azathioprine by mouth 50 mg twice daily, two weeks before admission. His only other medication at this time was ketoprofen 200mg daily, which he had commenced two years previously. During the fortnight preceding admission he developed progressive anorexia, nausea and vomiting, with myalgia and night sweats. He became icteric and developed 3 cm tender, uniform hepatomegaly. A full blood count at this time showed a haemoglobin of 12.2 g/dl, white cell count of 8.3 x 109/l, with 0.83 x 109/l eosinophils, and platelet count of 382 x 109/l. Urea and electrolytes were normal; liver function tests showed a bilirubin of 39 mmol/l (normal range 0-17), alkaline phosphatase 898 IU/l (normal range 100-300) and aspartate transaminase greater than 300 IU/l (normal range 32-50), with normal serum total protein and albumin levels. Hepatitis B surface antigen was not detected, Monospot testing was negative, and complement fixation tests for hepatitis A, cytomegalovirus, toxoplasma and mycoplasma were negative. Serum immunoglobulin and complement levels were normal.
A liver ultrasound scan was normal, but technetium scintigraphy revealed patchy uptake suggestive of moderate hepatocellular damage. Liver biopsy showed a normal liver architecture with no hepatocellular necrosis or cholestasis. There was marked lipofuscin deposition throughout the specimen (Figure 1) . These results were confirmed on electronmicroscopy.
On admission to hospital, azathioprine was withdrawn and the patient continued on ketoprofen. Symptomatic improvement occurred within four days, followed by complete resolution ofbiochemical hepatic dysfunction and jaundice within two weeks. The eosinophilia settled to less than 1%, and at Figure 1 . Routine liver biopsy showing normal structure and pronounced lipofuscin deposits. There is no evidence of hepatocellular necrosis or cholestasis one month the bilirubin, alkaline phosphatase and transaminase were all normal.
Eight months later the patient developed dyspnoea and was found to have a squamous cell carcinoma of the right upper lobe bronchus which was treated by pneumonectomy. He made a good postoperative recovery and was discharged from hospital. One month later he collapsed suddenly with dyspnoea, central cyanosis and hypotension. Despite attempted resuscitation, he succumbed at home. Post-mortem examination was declined and death was attributed to massive pulmonary embolism.
Discussion
The development of anorexia, vomiting and hepatocellular jaundice with eosinophilia after two weeks of treatment with azathioprine, and prompt subsidence on withdrawal of the drug, strongly suggest a hypersensitivity reaction.
Azathioprine has a beneficial effect on the course of rheumatoid arthritis"3 and has also made possible a reduction in the steroid dose required for prolonged treatment4'5. Hypersensitivity to azathioprine manifests in a variety of ways: pancreatitis6, meningitis7, skin rashes8, and arthralgia9 have all been recorded. The most important allergic phenomenon, however, is the occurrence of hepatic dysfunction. Cholestatic jaundice has been described in patients receiving azathioprine following renal transplantation2 0, and a syndrome of portal fibrosis is also recognized". The association of hepatocellular necrosis with azathioprine hypersensitivity is less well documented. In a review of 542 patients with rheumatoid arthritis who were being treated with azathioprine, hepatotoxicity was documented in only 2 cases, both developing a cholestatic hepatitis'2. Zarday and colleagues3 reported a case of post-transplant hepatocellular necrosis in a patient treated with azathioprine, but the picture was complicated both by the concomitant use of isoniazid and also the special circumstances surrounding transplantation. Cholestasis was not detected biochemically or histologically in our patient. The patchy pattern of isotope uptake and absence of hepatocellular damage on the liver biopsy, combined with the biochemical picture, are strongly suggestive of focal hepatocellular necrosis, a hitherto undescribed variant of azathioprine hypersensitivity.
Although mild disturbances of liver function and histology are well recognized in rheumatoid arthritis'3 these are subacute or chronic and do not resemble the acute self-limiting hepatitis which occurred in our patient.
The only other medication used in the two years prior to this illness had been ketoprofen. Animal and human studies of this drug have failed to show any association with hepatotoxicity; this, together with the temporal relationship of eosinophilia and jaundice to azathioprine administration, exclude ketoprofen as a plausible causative agent.
The cause of lipofuscin deposition in the liver is more contentious. It is generally accepted that lipofuscin is a waste product which accumulates within cells, and that its presence is an indicator of cellular inefficiency'4. It is not an uncommon finding in liver biopsy specimens from a hospital population (15% in one study'5); and any search for a connection between pathological processes and the pigmentation must be restricted to cases with greater than the normal age-related deposition of ceroid pigment".5 Large amounts of lipofuscin have been demonstrated in the livers of patients following excessive intake of phenacetin"6, but not to date in patients taking either ketoprofen or azathioprine. The histological and electron microscopy findings in the case rule out diffuse disease and, by exclusion, strongly suggest a focal pattern of hepatic necrosis.
Obstructive jaundice secondary to carcinoma arising in Brunner's glands Carcinoma of Brunner's glands is an exceptionally rare tumour with specific histological features that differentiate it from other duodenal tumours. A case is presented of obstructive jaundice arising as a result of this disease and its successful treatment by radical pancreatoduodenectomy.
Case report A 51-year-old man presented with a three-day history of jaundice, pruritus, pale stools and dark urine. He also described constant epigastric pain which had been present for one year, associated with a weight loss of 6 kg. Cimetidine had been prescribed to control the pain but without improvement.
Examination revealed a fit-looking man with jaundice and multiple excoriations of the skin as a result of pruritus. He was apyrexial and there were no other manifestations of chronic liver disease. The liver felt firm and smooth and the edge was palpable two finger-breadths below the right costal margin. A distended gallbladder was not felt.
The serum bilirubin was 108 gmol/l (normal < 17) with an alkaline phosphatase of 1004 IU/l (normal <275). All other haematological and biochemical parameters were within normal limits. Ultrasound of the upper abdomen suggested hepatomegaly with a non-distended calculous gallbladder.
At laparotomy the common bile duct and gallbladder were found to be distended. There was no evidence of gallstones. A discrete mass was palpable within the head of the pancreas. Inspection via a duodenotomy showed a neoplasm arising from the ampulla of Vater. A standard radical pancreatoduodenectomy preserving the tail of the pancreas (Whipple's operation) was performed.
Postoperatively prophylactic parenteral nutrition was administered. A pancreatic fistula developed but this closed spontaneously. At 18 months follow up there had been no problems, the patient had maintained a satisfactory weight and had not developed glycosuria.
Examination of the excised specimen revealed a nodular, exophytic lesion arising from the medial wall of the duodenum, adjacent to the papilla of Vater. Histologically this was a mucus-secreting adenocarcinoma infiltrating lamina propria, muscularis mucosae and submucosa. Some sections showed malignant cells apparently merging with the normal Brunner's gland epithelial cells at the base of the mucosal crypts (Figure 1 ).
Primary malignant tumours of the duodenum, excluding carcinoma of the ampulla of Vater, are rare. Most authors accept the incidence as 0.35% of all gastrointestinal tumours'. The majority of adenocarcimomas arise from duodenal mucosa and account for about 80% of tumours. The remainder are lymphomas, malignant carcinoids, leiomyosarcomas and Brunner's gland tumours2 -s. 0141-0768/86/ 030173-02/$02.00/0 @ 1986
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